Ben Schwartz

Ben Schwartz is an accomplished professional with extensive experience in neuroimmunology and biopharma marketing. Currently serving as Director of Neuroimmunology Operations at Genentech since August 2022, Ben previously held the position of Associate Director of Global Market Planning at Denali Therapeutics from June 2021 to July 2022. At Genentech, Ben advanced through various roles related to the Ocrevus product line, including Senior Marketing Manager and Marketing Manager, where responsibilities included managed care marketing, site-of-care strategy development, and leading critical initiatives like the COVID-19 access-to-infusion task force. Prior experience at ZS Associates involved consulting for large biopharma organizations on portfolio strategy and market entry strategies. Ben holds a Bachelor of Science in Neuroscience from UCLA, earned in 2012.